The company aims to acquire and develop biopharmaceutical products as well as provide preclinical CRO services. The company may engage in any business and take measures that are suitable to promote the company's purpose directly or indirectly, such as acquiring, managing, using, encumbering, and disposing of businesses of all kinds, real estate, and intellectual property rights, both domestically and abroad, establishing branches and agencies, granting loans, managing capital, and providing guarantees in favor of affiliated companies.